Proc. NatL Acad. Sci. USA Vol. 79 Communicated by Victor A. McKusick, June 7, 1982 ABSTRACT The addition offresh medium supplemented with partially purified platelet-derived growth factor (PDGF) to quiescent density-arrested cultures ofBALB/c-3T3 cells decreases the subsequent binding of radiolabeled epidermal growth factor (EGF). The decrease in EGF binding can be observed 1 hr after the addition of PDGF. This effect is maximal in 2-3 hr, and binding remains diminished for at least 6 hr. These effects can be accounted for by a decrease in the number of EGF receptors with no change in receptor affinity. The action of PDGF is concentration dependent, but even at very high concentrations ofPDGF the reduction in EGF binding is never more than 50%. Similar decreases in EGF binding are produced by other treatments that render BALB/c-3T3 cells competent, such as the addition of fibroblast growth factor or medium previously exposed to the macrophage-like cell line P388D1. Cholera toxin (choleragen), which alone had no effect on EGF binding, dramatically potentiated the ability of PDGF to down regulate EGF receptors. Two to three hours after the addition of PDGF and choleragen, EGF binding was reduced by 80-90% compared with control values. The ability of PDGF and choleragen together to decrease EGF binding was substantially inhibited by cycloheximide. Autoradiography of [3HJthymidine-labeled cells shows that choleragen potentiates the action of PDGF; lower concentrations of PDGF are required to make cells competent after choleragen treatment. Furthermore, cells treated with PDGF and choleragen no longer require EGF for traverse ofG1 phase and initiation of DNA synthesis in defined medium. The reduction in receptor number produced by choleragen and PDGF, which may be due to internalization of the EGF receptor, may mimic the action of EGF and thereby remove the EGF requirement for DNA synthesis.
The serum-derived factors that control Go/G1 traverse in density-arrested BALB/c-3T3 cells can be divided into two functionally distinct components (1). Platelet-derived growth factor (PDGF) acts initially to render cells competent to respond to serum-derived factors (progression factors) that are also present in platelet-poor plasma (1, 2) . Competent PDGF-treated cells traverse GO/GI and initiate DNA synthesis a minimum of 12 hr after the addition of medium supplemented with plasma (1, 2). Furthermore, a combination of epidermal growth factor (EGF) and somatomedin C in defined medium is as effective as plasma-supplemented medium in promoting the progression of competent BALB/c-3T3 cells (3).
The biochemical mechanisms by which PDGF renders cells sensitive to EGF and somatomedin C are ofgreat interest. Peptide factors might act in concerted fashion if one were able to modulate either the number or affinity of the receptors for another peptide. Clemmons (7) . Enhanced loss of EGF receptors after treatment with PDGF and choleragen was coincidental with an abrogation ofthe EGF requirement for progression to S phase of the cell cycle.
MATERIALS AND METHODS
Cell Culture. BALB/c-3T3 cells (clone A31) were grown in Dulbecco-Vogt modified Eagle's (DME) medium/10% heatinactivated calf serum/4 mM glutamine, supplemented with penicillin at 50 units/ml and streptomycin at 50 ,g/ml in humidified 5% C02/95% air at 37°C.
Binding Studies. To prepare cells for binding studies, approximately 3 x 10' cells suspended in 2 ml of serum-supplemented DME medium were plated in 35-mm culture dishes. The medium was changed after 3 days and the cells were used 5 to 6 days later. After treatment at 370C with DME medium containing 0.25% platelet-poor plasma (DME-LP medium), cultures were placed on ice and washed with Hanks' buffered salt solution containing 30 mM Hepes, pH 7.4/0.1% bovine serum albumin (medium A) at 4°C. Plates were then incubated for 4 hr at 40C in 0.5 ml of medium A containing '251-labeled EGF. Nonspecific binding was determined in the presence of native EGF at 1 ,ug/ml. At the end of the incubation period, cultures were washed three times with 2 ml ofcold medium A, and bound 125I-labeled EGF was solubilized in 0.1 M NaOH/ 1% NaDodSO4 and assayed in a gamma counter. Only specific binding is shown in the figures and tables. All studies were repeated at least three times with similar results. Binding equilibrium is at least 95% complete at 3 hr.
DNA Synthesis Assay. Cells were grown to confluence in 96-well microtiter plates containing serum-supplemented DME medium at 0.2 ml per well. Two to three days after the cells reached density-dependent growth arrest, the medium was changed to DME medium containing [3H]thymidine at 5 ,tCi/ Abbreviations: DME medium, Dulbecco-Vogt modified Eagle's medium; DME-LP medium, DME medium containing 0.25% plateletpoor plasma; PDGF, platelet-derived growth factor; EGF, epidermal growth factor; FGF, fibroblast growth factor. I I To whom reprint requests should be addressed.
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5568 Cell Biology: Wharton et aL ml (6.7 Ci/mmol; 1 Ci = 3.7 X 1010 becquerels) and various supplements. At the end of the experiment, cells were fixed with methanol and processed for autoradiography as described (1) . Preparation of Growth Factors. Partially purified PDGF was prepared from boiled extracts of outdated human platelets as described by Antoniades and Scher (8) . Preparations of PDGF were chromatographed on CM-Sephadex and then in 1 M acetic acid on Bio-Gel P-150. Active fractions were collected, pooled, and lyophilized. Platelet-poor plasma was prepared as described by Pledger et al (1) from peripheral venous blood drawn from healthy volunteers. EGF was purified from mouse submaxillary glands by the procedure of Savage and Cohen (9) and was labeled with Na'15I to a specific activity of 1.2 Ci/pumol by the method of Hunter and Greenwood (10) as described (11) . Fibroblast growth factor was a gift from D. Gospodarowicz. Bovine insulin was purchased from Sigma.
Materials. DME medium was purchased from Flow Laboratories. Antibiotics were from GIBCO, and serum was from Colorado Serum Company (Denver, CO). Microtiter plates were from Nunc (GIBCO). Other plastic culture ware was from Fisher Scientific, and chemicals were purchased from Sigma. RESULTS PDGF-Induced Decrease in EGF Binding. Addition of DME-LP medium supplemented with partially purified PDGF to quiescent density-arrested cultures of BALB/c-3T3 cells rapidly decreased the ability of the cells to bind "2I-labeled EGF (Fig. 1A) . When DME-LP medium alone was added to quiescent cultures, there was no change in "2I-labeled EGF binding over a 4-hr period. When medium containing partially purified PDGF at 2.5 ug/ml was added, however, binding of 15I-labeled EGF decreased 25% within 1 hr and to 45% of control levels within 3 hr. Between 3 and 5 hr after addition of PDGF, there was no further reduction in binding. These results are similar to those observed after addition ofEGF to cultured cells. In what has been termed down regulation, EGF induces a specific decrease in the number of EGF membrane receptors (12, 13) . The effects of our partially purified PDGF preparations cannot be attributed to contamination by EGF because, both 6 A .~B 2- by radioreceptor assay and by radioimmunoassay, the undiluted PDGF did not contain detectable (0.1 ng/ml) amounts of EGF (data not shown). This effect was also not due to a general decrease in membrane hormone receptors, because the preparation of PDGF used in these experiments did not alter somatomedin C binding (data not shown), in agreement with the results of Clemmons and Van Wyk (4) .
Potentiation of PDGF Action by Choleragen. We have previously found that choleragen, a potent activator of adenylate cyclase in cultured cells (14) , potentiates the ability of PDGF to render cells competent (7) . Choleragen also potentiated the ability of PDGF to reduce '25I-labeled EGF binding to BALB/ c-3T3 cells (Fig. 1B) . Addition ofeither DME-LP medium alone or DME-LP medium containing choleragen at 1 ,g/ml to quiescent cells did not change " I-labeled EGF binding. Addition of DME-LP supplemented with partially purified PDGF at 5 pug/ml caused a 50% reduction in EGF binding within 2 hr, similar to the results shown in Fig. 1A ; addition of medium containing both PDGF and choleragen, however, produced a much more dramatic decrease in EGF binding. By 1 hr after addition, EGF binding was decreased by 40%, and by 4 hr, the combination of PDGF and choleragen had almost abolished the ability of the cells to bind "2I-labeled EGF.
As shown in Fig. 2 , the effect of PDGF on EGF binding was concentration dependent in both the presence and the absence ofcholeragen. When medium supplemented with PDGF alone was added to quiescent BALB/c-3T3 cells for 4 hr, there was a concentration-dependent decrease in 1"I-labeled EGF binding. A maximum reduction in binding ofapproximately 50% was observed at PDGF concentrations of either 0.75 or 1.0 pug/ml when PDGF purified on Bio-Gel P-150 was used. In experiments not shown, the PDGF concentration was increased to 10 ,ug/ml with no further decrease in binding over that shown in Fig. 2 . In the presence of choleragen at 1.0 ug/ml, PDGF caused a much greater reduction in "I-labeled EGF binding.
At 0.25 jug/ml, PDGF reduced EGF binding by more than 40% and, at 1 jg/ml, PDGF reduced EGF binding by approximately 90%. In the presence ofcholeragen, therefore, not only did PDGF decrease "2I-labeled EGF binding at lower con- centrations, but the magnitude ofthe decrease was greater than that observed with PDGF alone, even when very high concentrations were added. In contrast, choleragen did not affect down Proc. Nad Acad. Sci 
There is a lag following the addition of choleragen before maximal effects on adenylate cyclase are observed (14) . As shown in Fig. 3 of the receptors for "25I-labeled EGF, or some combination of both effects. To distinguish between these alternatives, sets of quiescent cultures were incubated for 4 hr in DME-LP medium alone or DME-LP medium containing partially purified PDGF Effects of Cycloheximide on PDGF-Induced Down Regulation of EGF Receptors. The ability of EGF to modulate the number of EGF receptors on target cells occurs in the presence ofcycloheximide (13) . Incubation ofcells in cycloheximide alone produces a slow decrease in EGF binding in cells not exposed to EGF. In contrast, the reduction in EGF binding produced by PDGF alone or by PDGF and choleragen together was strictly dependent on continued protein synthesis ( Quiescent BALB/c-3T3 cells were incubated for 36 hr in DME medium supplemented with the indicated combinations of partially purified PDGF (3.1 W'ml), EGF (10 ng/ml), and insulin (10 pM) in the presence or absence of choleragen at 1 ,ug/ml. All culture media also contained [5H]thymidine at 5 gCi/ml. At the end of the incubation period, the cells were fixed with methanol and processed for autoradiography, and the percentage of cells incorporating [5Hlthymidine was determined. The PDGF concentration in these experiments induced 82% of the cells to undergo DNA synthesis in the presence of 5% platelet-poor plasma. At this high concentration of PDGF, addition of choleragen had little effect' when the cells were incubated in 5% plasma-containing medium. Similar results were obtained in four experiments.
can be studied rigorously through the use of purified growth factors. PDGF apparently acts initially in the cell cycle to render cells competent to respond either to the progression factors in platelet-poor plasma (1, 2) or to purified EGF together with somatomedin C (or insulin at higher concentrations) (3). The biochemical mechanisms by which PDGF allows cells to respond to EGF or insulin-like growth factors are important growth-controlling events. Pledger et aL (18) have shown that specific cellular proteins are preferentially synthesized when BALB/c-3T3 cells. are exposed to competence factors. Both PDGF and FGF induce competence formation and down regulate receptors for EGF, a progression factor. The importance in the mitogenic response of down regulation of receptors by the same factor (homologous down regulation) or by another factor (heterologous down regulation) is unknown. Transient down regulation of EGF receptors by PDGF has been described (5) . We have demonstrated a more persistent effect by PDGF and FGF that is concentration dependent and, like EGF-induced down regulation, is associated with loss of binding sites with no change in affinity (Figs. 2 and 4) .
Choleragen has been reported to stimulate proliferative growth in epidermal cells (19) , endothelial cells (20) , and mouse fibroblasts (7, 21, 22) . Through study ofsequential events using PDGF and plasma, we recently demonstrated that the stimulatory action of choleragen and other agents elevating intracellular cAMP is on the early events associated with competence formation, since choleragen reduces the concentration of PDGF required for maximal (greater than 90%) stimulation of DNA synthesis in quiescent BALB/c-3T3 cells; i.e., it potentiates competence factors but is inactive alone or when added after competence formation during progression (7). This potentiation appears to be cAMP mediated, since it is, also found to occur with 8-bromo-cAMP, is enhanced by isobutylmethylxanthine, and does not occur with choleragenoid (data not shown).
We have found that choleragen, which by itselfhas no effect (23) , to the EGF receptor (24) , and to the catecholamine receptor (25) have been shown to simulate the action of the natural ligand. Antibody to the EGF receptor is mitogenic (24) , indicating that EGF is not required, not only for short-term effects such as phosphorylation, but also for the long-term effect DNA synthesis. Similar results were found when antibodies to EGF, used presumably to crosslink a nonmitogenic derivative of EGF (cyanogen bromide-treated EGF), rendered the derivative capable of initiating DNA synthesis (26) . These findings suggest that crosslinking ofreceptors followed by clustering and internalization may be significant effects of the natural ligands with respect to biologic action.
In both PDGF-treated cells and cells treated with choleragen and PDGF together, the readiness ofthe cell to begin cell cycle traverse is associated with a decrease in EGF binding. Viral transformation is associated with both a decrease in EGF binding (27) and loss ofthe requirement for competence factors (15) . During liver regeneration in rats, a dramatic decrease in EGF binding occurs (28) . A prompt decrease in EGF receptors occurring in diverse settings associated with proliferative growth suggests that this may be part of an overall growth response by the cell. The demonstration in the present study that down regulation of EGF receptors by PDGF and choleragen permits fibroblasts to proceed to synthesize DNA in the absence of EGF, for which there is ordinarily an absolute requirement in defined medium, is also compatible with this general argument. Whether heterologous down regulation is accompanied by clustering and internalization of EGF receptors has not been determined; if so, the present results suggest that these actions ofthe receptor, whether induced by PDGF together with choleragen, anti-EGF receptor antibody, or EGF, may be required for mitogenesis. Anti-EGF antibody can effectively prevent the mitogenic action of EGF in human fibroblasts for up to 8 hr (12, 26 
